Nikorono Mint (Nicotine)

Nicotine, the active ingredient in Nikorono Mint, is a nicotinic receptor agonist presented as an oral formulation for oral use. It is employed to help adults who smoke reduce withdrawal symptoms and support quitting tobacco through controlled nicotine delivery and may aid in preventing relapse.

GNH USA supplies Nikorono Mint as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for healthcare providers across multiple regions globally.

Nikorono Mint, containing nicotine, acts on nicotinic acetylcholine receptors to alleviate nicotine dependence.

- Smoking cessation: assists adult smokers in quitting by reducing cravings and withdrawal symptoms. - Nicotine dependence: supports individuals with established nicotine addiction to transition away from tobacco use. - Relapse prevention: helps maintain abstinence by mitigating urges during the early cessation period.

Adverse reactions may occur with oral nicotine products and are categorized by frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Mouth irritation: tingling or soreness in the oral cavity. - Headache: transient tension-type headache. - Dizziness: light‑headed sensation, especially on initiation. - Insomnia: difficulty falling or staying asleep. - Increased salivation: excess saliva production.

Serious or Rare Side Effects: - Cardiovascular events: chest pain, palpitations, or hypertension. - Severe allergic reaction: rash, itching, swelling, or anaphylaxis. - Seizures: rare convulsive episodes. - Arrhythmia: irregular heart rhythm. - Hypotension: marked drop in blood pressure. - Respiratory distress: shortness of breath or bronchospasm.

When prescribing or dispensing Nikorono Mint, consider the following safety measures. - Cardiovascular assessment: evaluate patients with known heart disease before use. - Hypertension monitoring: avoid in uncontrolled high blood pressure. - Non‑smoker caution: not indicated for individuals who do not use tobacco. - Dependence risk: monitor for signs of nicotine overuse or dependence. - Concomitant NRT: avoid simultaneous use of multiple nicotine replacement products. - Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture and direct sunlight.

Nicotine may interact with other medicines, altering its effects or increasing risk.

Major Interactions (Avoid): - Other nicotine replacement therapies: risk of nicotine overdose. - Monoamine oxidase inhibitors (MAOIs): heightened cardiovascular stimulation. - Bupropion: increased seizure potential when combined.

Moderate Interactions (Monitor Closely): - CYP2A6 inhibitors (e.g., cimetidine): may raise nicotine plasma levels. - Beta‑blockers: nicotine‑induced tachycardia may be masked. - Antidepressants (SSRIs): possible alteration of nicotine metabolism. - Antihypertensives: nicotine may reduce efficacy of blood‑pressure control.